Cargando…
The Counter Regulatory Axis of the Lung Renin-Angiotensin System in Severe COVID-19: Pathophysiology and Clinical Implications
The severe acute respiratory syndrome coronavirus (SARS-CoV)-2, which is responsible for coronavirus disease 2019 (COVID-19), uses angiotensin (ANG)-converting enzyme 2 (ACE2) as the entrance receptor. Although most COVID-19 cases are mild, some are severe or critical, predominantly due to acute lun...
Autores principales: | Triposkiadis, Filippos, Starling, Randall C., Xanthopoulos, Andrew, Butler, Javed, Boudoulas, Harisios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831862/ https://www.ncbi.nlm.nih.gov/pubmed/33454213 http://dx.doi.org/10.1016/j.hlc.2020.11.008 |
Ejemplares similares
-
ACE2, the Counter-Regulatory Renin–Angiotensin System Axis and COVID-19 Severity
por: Triposkiadis, Filippos, et al.
Publicado: (2021) -
Renin-angiotensin-system inhibition in the context of corona virus disease-19: experimental evidence, observational studies, and clinical implications
por: Triposkiadis, Filippos, et al.
Publicado: (2020) -
Fallacies in medical practice: Renin-angiotensin-aldosterone system inhibition and COVID-19 as a Paradigm
por: Triposkiadis, Filippos, et al.
Publicado: (2021) -
The Interventricular Septum: Structure, Function, Dysfunction, and Diseases
por: Triposkiadis, Filippos, et al.
Publicado: (2022) -
Aortic Stiffness: A Major Risk Factor for Multimorbidity in the Elderly
por: Triposkiadis, Filippos, et al.
Publicado: (2023)